Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-27T02:25:09.042Z Has data issue: false hasContentIssue false
  • English
  • Français

Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia

Published online by Cambridge University Press:  24 January 2020

Guillaume Butler-Laporte Open the ORCID record for Guillaume Butler-Laporte [Opens in a new window] ,
Matthew P. Cheng Open the ORCID record for Matthew P. Cheng [Opens in a new window] ,
Emily G. McDonald  and
Todd C. Lee Open the ORCID record for Todd C. Lee [Opens in a new window]
Guillaume Butler-Laporte*
Affiliation:
Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada Division of Medical Microbiology, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada
Matthew P. Cheng
Affiliation:
Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada Division of Medical Microbiology, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada McGill Interdisciplinary Initiative in Infection and Immunity, Montréal, Quebec, Canada
Emily G. McDonald
Affiliation:
McGill Interdisciplinary Initiative in Infection and Immunity, Montréal, Quebec, Canada Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, Quebec, Canada
Todd C. Lee
Affiliation:
Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada McGill Interdisciplinary Initiative in Infection and Immunity, Montréal, Quebec, Canada Division of General Internal Medicine, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada Clinical Practice Assessment Unit, McGill University Health Centre, Montréal, Quebec, Canada
*
Author for correspondence: Guillaume Butler-Laporte, E-mail: guillaume.butler-laporte@mail.mcgill.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

Background and objective:

Enterococcus causes clinically significant bloodstream infections (BSIs). In centers with a higher prevalence of vancomycin resistant enterococcus (VRE) colonization, a common clinical question is whether empiric treatment directed against VRE should be initiated in the setting of a suspected enterococcal BSI. Unfortunately, VRE treatment options are limited, and relatively expensive, and subject patients to the risk of adverse reactions. We hypothesized that the results of VRE colonization screening could predict vancomycin resistance in enterococcal BSI.

Methods:

We reviewed 370 consecutive cases of enterococcal BSI over a 7-year period at 2 tertiary-care hospitals to determine whether vancomycin-resistant BSIs could be predicted based on known colonization status (ie, patients with swabs performed within 30 days, more remotely, or never tested). We calculated sensitivity and specificity, and we plotted negative predictives values (NPVs) and positive predictive values (PPVs) as a function of prevalence.

Results:

A negative screening swab within 30 days of infection yielded NPVs of 90% and 95% in settings where <27.0% and 15.0% of enterococcal BSI are resistant to vancomycin, respectively. In patients with known VRE colonization, the PPV for VRE in enterococcal BSI was >50% at any prevalence exceeding 25%.

Conclusions:

The results of a negative VRE screening test result performed within 30 days can help eliminate unnecessary empiric therapy in patients with suspected enterococcal BSI. Conversely, patients with positive VRE screening swabs require careful consideration of empiric VRE-directed therapy when enterococcal BSI appears likely.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 41 , Issue 4 , April 2020 , pp. 425 - 429
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ramsey, AM, Zilberberg, MD.Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000–2006. Infect Control Hosp Epidemiol 2009;30:184–186.CrossRefGoogle ScholarPubMed
Fridkin, SK, Edwards, JR, Courval, JM, et al.The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 2001;135:175–183.CrossRefGoogle Scholar
Suppola, JP, Volin, L, Valtonen, VV, Vaara, M.Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis 1996;23:694–697.CrossRefGoogle ScholarPubMed
Mikulska, M, Del Bono, V, Raiola, AM, et al.Bloodstream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 2009;15:47–53.CrossRefGoogle Scholar
Bedini, A, Codeluppi, M, Cocchi, S, et al.Gram-positive bloodstream infections in liver transplant recipients: incidence, risk factors, and impact on survival. Transplant Proc 2007;39:1947–1949.CrossRefGoogle ScholarPubMed
French, G.Safety and tolerability of linezolid. J Antimicrob Chemother 2003;51 suppl 2:ii45–ii53.CrossRefGoogle ScholarPubMed
Foolad, F, Taylor, BD, Shelburne, SA, Arias, CA, Aitken, SL.Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review. J Antimicrob Chemother 2018;73:2277–2283.CrossRefGoogle ScholarPubMed
Chuang, Y-C, Lin, H-Y, Chen, P-Y, et al.Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia. Clin Infect Dis 2017;64:1026–1034.CrossRefGoogle ScholarPubMed
Bagga, B, Buckingham, S, Arnold, S, Nesbitt, A, Guimera, D, Lee, K.Increasing linezolid-resistant Enterococcus in a children’s hospital. Pediatr Infect Dis J 2018;37:242–244.CrossRefGoogle ScholarPubMed
Ye, J Jr, Shie, S-S, Cheng, C-W, et al.Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia. J Microbiol Immunol Infect 2018;51:705–716.CrossRefGoogle ScholarPubMed
Butler-Laporte, G, Cheng, MP, Cheng, AP, McDonald, EG, Lee, TC.Using MRSA screening tests to predict methicillin resistance in Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2016;60:7444–7448.Google ScholarPubMed
Butler-Laporte, G, De L’Etoile-Morel, S, Cheng, MP, McDonald, EG, Lee, TC.MRSA colonization status as a predictor of clinical infection: a systematic review and meta-analysis. J Infect 2018;77:489–495.CrossRefGoogle ScholarPubMed
Brasg, I, Elligsen, M, MacFadden, D, Daneman, N.Predictive utility of swab screening for vancomycin-resistant Enterococcus in selection of empiric antibiotics for Enterococcus sterile-site infections: a retrospective cohort study. CMAJ Open 2017;5(3):E632–E637.CrossRefGoogle ScholarPubMed
Webb, BJ, Healy, R, Majers, J, et al.Prediction of bloodstream infection due to vancomycin-resistant Enterococcus in patients undergoing leukemia induction or hematopoietic stem-cell transplantation. Clin Infect Dis 2017;64:1753–1759.CrossRefGoogle ScholarPubMed
Clinical and Laboratory Standards Institute. CLSI Document M100. Performance Standards for Antimicrobial Susceptibility Testing, 29th edition. Wayne, PA: CLSI; 2019.Google Scholar
McCracken, M, Wong, A, Mitchell, R, et al.Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999–2009. J Antimicrob Chemother 2013;68:1505–1509.CrossRefGoogle ScholarPubMed
McDonald, EG, Dendukuri, N, Frenette, C, Lee, TC.Time-series analysis of health care-associated infections in a new hospital with all private rooms. JAMA Intern Med 2019;179:1501–1506.CrossRefGoogle Scholar
Efron, B, Tibshirani, RJ.An Introduction to the Bootstrap, vol. 57, 1st ed. New York: Chapman and Hall; 1993.CrossRefGoogle Scholar
Butler-Laporte, G, Cheng, MP, McDonald, EG, Lee, TC.Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia. BMC Infect Dis 2018;18:270.CrossRefGoogle ScholarPubMed
Rubinstein, M, Hirsch, R, Bandyopadhyay, K, et al.Effectiveness of practices to support appropriate laboratory test utilization: a laboratory medicine best practices systematic review and meta-analysis. Am J Clin Pathol 2018;149:197–221.CrossRefGoogle ScholarPubMed
Bossaer, JB, Hall, PD, Garrett-Mayer, E.Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2011;19:231–237.CrossRefGoogle Scholar
Ford, CD, Lopansri, BK, Haydoura, S, et al.Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infection Control Hosp Epidemiol 2015;36:47–53.CrossRefGoogle ScholarPubMed
MacFadden, DR, Coburn, B, Shah, N, et al.Utility of prior cultures in predicting antibiotic resistance of bloodstream infections due to gram-negative pathogens: a multicentre observational cohort study. Clin Microbiol Infect 2018;24:493–499.CrossRefGoogle ScholarPubMed
Supplementary material: File

Butler-Laporte et al. supplementary material

Butler-Laporte et al. supplementary material

Download Butler-Laporte et al. supplementary material(File)
File 262.5 KB